JOYANG LABORATORIES

Overview

JOYANG LABORATORIES is an active pharmaceutical ingredient (API) supplier with 9 active FDA Type II Drug Master Files, covering ADENOSINE; BACITRACIN; BACITRACIN ZINC; CYCLOSPORINE (NON-STERILE BULK FORM); FUSIDIC ACID; MYCOPHENOLATE MOFETIL.

API / Drug Master Files

JOYANG LABORATORIES holds 9 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PIOGLITAZONE HYDROCHLORIDEActive2025-11-27
• MYCOPHENOLATE MOFETILActive2025-10-30
• MYCOPHENOLATE SODIUMActive2024-12-19
• ADENOSINEActive2024-10-25
• SODIUM FUSIDATEActive2021-10-08
• BACITRACINActive2015-04-07
• FUSIDIC ACIDActive2015-01-31
• BACITRACIN ZINCActive2013-11-25
• CYCLOSPORINE (NON-STERILE BULK FORM)Active2005-09-06
• TacrolimusInactive2020-03-03
• BACITRACIN USPInactive2011-10-10
• BACITRACIN ZINCInactive2011-06-24

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to JOYANG LABORATORIES in our records. PharmaTek screens the full directory against live FDA enforcement data.